Suzanne Beauchene on the Provenge Treatment Process

Suzanne Beauchene, BSN, RN
Published: Friday, May 20, 2011

Suzanne Beauchene, BSN, RN, RD, from Seattle Cancer Care Alliance in Seattle, WA discusses the Provenge process starting with a collection of the immune cells using leukapheresis. Once the cells are collected they are sent to a manufacturing facility and mixed with the protein then the Provenge is sent back and given to the patient.

Suzanne Beauchene, BSN, RN, RD, from Seattle Cancer Care Alliance in Seattle, WA discusses the Provenge process starting with a collection of the immune cells using leukapheresis. Once the cells are collected they are sent to a manufacturing facility and mixed with the protein then the Provenge is sent back and given to the patient.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x